- Capital Cube•5 days ago
Click here to see latest analysisCapitalcube gives NeoGenomics, Inc. a score of 41.Our analysis is based on comparing NeoGenomics, Inc. with the following peers – RadNet, Inc., Quest Diagnostics Incorporated, Psychemedics Corporation, Laboratory Corporation of America Holdings, Enzo Biochem, Inc., CombiMatrix Corporation, GeneLink, Inc. and Interleukin Genetics, Inc. (RDNT-US, DGX-US, PMD-US, LH-US, ENZ-US, CBMX-US, GNLKQ-US […] (Read more...) The post NeoGenomics, Inc. – Value Analysis (NASDAQ:NEO) : July 18, 2016 appeared first on CapitalCube.
After hours: 9.310.00 (0.00%) as of 4:44 PM EDT
|Bid||9.29 x 100|
|Ask||9.40 x 1000|
|52wk Range||5.26 - 9.54|
|Day's Range||9.21 - 9.37|
|Avg Vol (3m)||547,615|
As of 4:00 PM EDT. Market closed.